We are live on ! Find out more
FT

Fiduciary Trust Portfolio holdings

AUM $8.46B
1-Year Est. Return 21.38%
This Fund
S&P 500
This Quarter Est. Return
+9.74%
1 Year Est. Return
+21.38%
3 Year Est. Return
+65.44%
5 Year Est. Return
+79.3%
10 Year Est. Return
+269.63%
AUM
$5.14B
AUM Growth
+$518M
Cap. Flow
+$132M
Cap. Flow %
2.56%
Top 10 Hldgs %
39.52%
Holding
648
New
37
Increased
171
Reduced
296
Closed
23

Sector Composition

Rank Sector Weight
1 Technology 13.06%
2 Consumer Discretionary 12.71%
3 Healthcare 11.1%
4 Financials 5.89%
5 Consumer Staples 4.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COF icon
601
Capital One
COF
$128B
$202K ﹤0.01%
+2,168
New +$213K
VOTE icon
602
TCW Transform 500 ETF
VOTE
$1.07B
$201K ﹤0.01%
+4,550
New +$203K
DPZ icon
603
Domino's
DPZ
$11.9B
$200K ﹤0.01%
+578
New +$202K
AMUB icon
604
ETRACS Alerian MLP Index ETN Series B due July 18 2042
AMUB
$59.6M
$187K ﹤0.01%
+13,633
New +$189K
HLN icon
605
Haleon
HLN
$45.3B
$184K ﹤0.01%
22,964
+7,758
+51% +$52.8K
NRIX icon
606
Nurix Therapeutics
NRIX
$2.45B
$155K ﹤0.01%
14,074
PASG icon
607
Passage Bio
PASG
$14.5M
$152K ﹤0.01%
5,500
+5,000
+1,000% +$126K
NOK icon
608
Nokia
NOK
$46.9B
$151K ﹤0.01%
32,574
MCI
609
Barings Corporate Investors
MCI
$345M
$146K ﹤0.01%
10,437
TSVT
610
DELISTED
2seventy bio
TSVT
$142K ﹤0.01%
15,103
+2,043
+16% +$28.8K
BLUE
611
DELISTED
bluebird bio
BLUE
$105K ﹤0.01%
+755
New +$106K
ESBA icon
612
Empire State Realty Series ES
ESBA
$1.57B
$104K ﹤0.01%
16,000
EXG icon
613
Eaton Vance Tax-Managed Global Diversified Equity Income Fund
EXG
$2.91B
$103K ﹤0.01%
13,700
-1,900
-12% -$14.5K
UEC icon
614
Uranium Energy
UEC
$4.47B
$71.5K ﹤0.01%
18,419
+710
+4% +$2.7K
FHTX icon
615
Foghorn Therapeutics
FHTX
$278M
$69.4K ﹤0.01%
10,879
PMN icon
616
ProMIS Neurosciences
PMN
$126M
$44.1K ﹤0.01%
+406
New +$56.8K
TEF
617
DELISTED
Telefonica
TEF
$39.1K ﹤0.01%
10,950
QVCGA
618
DELISTED
QVC Group Inc Series A
QVCGA
$32.9K ﹤0.01%
403
UROY
619
Uranium Royalty Corp
UROY
$478M
$31.7K ﹤0.01%
13,370
JNCE
620
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$23.5K ﹤0.01%
21,185
MVIS icon
621
Microvision
MVIS
$84.8M
$23.5K ﹤0.01%
10,000
SNGX icon
622
Soligenix
SNGX
$5.36M
$18.4K ﹤0.01%
170
EGIO
623
DELISTED
Edgio, Inc. Common Stock
EGIO
$12.8K ﹤0.01%
283
CARM
624
DELISTED
Carisma Therapeutics
CARM
$12.6K ﹤0.01%
1,035
DNTH icon
625
Dianthus Therapeutics
DNTH
$5.69B
$12.1K ﹤0.01%
1,910

Similar funds

Fiduciary Trust's Q4 2022 Portfolio in Review

As of Q4 2022, Fiduciary Trust held 648 positions worth $5.14B, up 11% from $4.62B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Fiduciary Trust's Q4 2022 filing shows 37 new, 171 increased, 296 reduced and 23 closed positions. Its largest new stake was FT Energy Income Partners Strategy ETF: 4,703,533 shares worth $93.7M. The largest sale was Apple, an estimated $11.6M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Fiduciary Trust's largest Q4 2022 buy was FT Energy Income Partners Strategy ETF: 4,703,533 shares worth $93.7M.
  • Fiduciary Trust added most to Vanguard FTSE Developed Markets ETF in Q4 2022, an estimated $40.6M increase.
  • Fiduciary Trust's biggest Q4 2022 reduction was Apple, cutting an estimated $11.6M.
  • Fiduciary Trust fully exited Entegris in Q4 2022, selling an estimated $3.07M.
  • Fiduciary Trust's ten largest holdings make up 40% of its $5.14B portfolio in Q4 2022.
  • Fiduciary Trust opened 37 new positions and closed 23 in Q4 2022.
  • Fiduciary Trust's portfolio value rose 11% quarter-over-quarter to $5.14B.

Based on Fiduciary Trust's 13F filing for Q4 2022, filed 14 Feb 2023.